Avicenna Journal of Clinical Microbiology and Infection

Published by: Kowsar

Sequence Variation of the Pertussis Toxin S1 Subunit Encoding Gene in the Clinical Isolates of Bordetella pertussis in Iran

Maryam Hosseinpour 1 , Nazanin Jannesar Ahmadi 1 , Vajiheh Sadat Nikbin 1 and Fereshteh Shahcheraghi 1 , *
Authors Information
1 Pertussis Reference Laboratory, Department of Bacteriology, Pasteur Institute, Tehran, IR Iran
Article information
  • Avicenna Journal of Clinical Microbiology and Infection: August 01, 2015, 2 (3); e21384
  • Published Online: August 1, 2015
  • Article Type: Research Article
  • Received: June 21, 2014
  • Revised: June 6, 2015
  • Accepted: June 14, 2015
  • DOI: 10.17795/ajcmi-21384

To Cite: Hosseinpour M, Jannesar Ahmadi N, Nikbin V S, Shahcheraghi F. Sequence Variation of the Pertussis Toxin S1 Subunit Encoding Gene in the Clinical Isolates of Bordetella pertussis in Iran, Avicenna J Clin Microb Infec. 2015 ;2(3):e21384. doi: 10.17795/ajcmi-21384.

Abstract
Copyright © 2015, Hamadan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lapin JH. Whooping Cough, Springfield, Ill. 1943;
  • 2. Peleg AY, Hooper DC. Hospital-Acquired Infections Due to Gram-Negative Bacteria. N Engl J Med. 2010; 362(19): 1804-13[DOI]
  • 3. Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect. 2014; 142(4): 685-94[DOI][PubMed]
  • 4. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010; 10(1): 36-49[DOI][PubMed]
  • 5. Zarei S, Tehrani MJ, Akhoundi M, Zarnani A. [Early complications of diphtheria tetanus pertussis vaccine triple the number of 4-6 year old children in Tehran]. Payesh . 2007; 6(3): 273-83
  • 6. Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernandez J, Sisti F, et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol. 2007; 14(11): 1490-8[DOI][PubMed]
  • 7. Centers for Disease C. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2012; 61(25): 468-70[PubMed]
  • 8. Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2012; 3[DOI][PubMed]
  • 9. De Serres G, Boulianne N, Douville Fradet M, Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep. 1995; 21(5): 45-8[PubMed]
  • 10. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J. 1994; 13(5): 343-5[PubMed]
  • 11. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998; 66(2): 670-5[PubMed]
  • 12. Yao SM, Lin YC, Chou CY, Chen YY, Hsiao MJ, Chen HY, et al. Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol. 2005; 43(11): 5457-61[DOI][PubMed]
  • 13. King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, Diavatopoulos D, et al. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics. 2008; 9: 311[DOI][PubMed]
  • 14. De Schutter I, Malfroot A, Dab I, Hoebrekx N, Muyldermans G, Pierard D, et al. Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin Infect Dis. 2003; 36(11): 1391-6[DOI][PubMed]
  • 15. Byrne S, Slack AT. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis. 2006; 6: 53[DOI][PubMed]
  • 16. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L. Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis. 2012; 18(5): 767-74[DOI][PubMed]
  • 17. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, Mazurova I, et al. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol. 2007; 14(3): 234-8[DOI][PubMed]
  • 18. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis. 2000; 182(5): 1402-8[DOI][PubMed]
  • 19. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, Hallander H, et al. Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol. 2005; 43(8): 3681-7[DOI][PubMed]
  • 20. Fingermann M, Fernandez J, Sisti F, Rodriguez ME, Gatti B, Bottero D, et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine. 2006; 24(17): 3513-21[DOI][PubMed]
  • 21. Fry NK, Neal S, Harrison TG, Miller E, Matthews R, George RC. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun. 2001; 69(9): 5520-8[PubMed]
  • 22. Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J. Pertussis in Poland. Int J Epidemiol. 2004; 33(2): 358-65[DOI][PubMed]
  • 23. Hopkins RS, Jajosky RA, Hall PA, Adams DA, Connor FJ, Sharp P, et al. Summary of notifiable diseases--United States, 2003. MMWR Morb Mortal Wkly Rep. 2005; 52(54): 1-85[PubMed]
  • 24. Litt DJ, Neal SE, Fry NK. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol. 2009; 47(3): 680-8[DOI][PubMed]
  • 25. Njamkepo E, Rimlinger F, Thiberge S, Guiso N. Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine. 2002; 20(9-10): 1290-4[PubMed]
  • 26. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002; 185(10): 1448-53[DOI][PubMed]
  • 27. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR. Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One. 2012; 7(9)[DOI][PubMed]
  • 28. Nikbin VS, Shahcheraghi F, Lotfi MN, Zahraei SM, Parzadeh M. Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran. Iran J Microbiol. 2013; 5(3): 209-14[PubMed]
  • 29. Shahcheraghi F LMPMNVSFZS. Isolation of Bordetella pertussis and parapertussis from clinical samples collected from all over Iran. Mazandaran Univ Med Sci. 2012; 22(88): 2-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments